Clinical Trial

Influence of Residual Bone Height on Marginal Bone Loss Around Implants Following Lateral Sinus Floor Augmentation With Deproteinized Bovine Bone Mineral

Completed
View on ClinicalTrials.gov →
Summary
Data collection will be done on all patients who underwent a lateral maxillary sinus floor augmentation in the Faculty of Dental Medicine, both in the Periodontology Department and in the Oral Surgery Department. Pre-surgical residual bone height will be measured on patients with a preoperative CBCT, and marginal bone loss will be measured in patients with a postoperative periapical radiograph that dates at least 3 years after implant placement. In contrast to other studies who only associated between the presurgical residual bone height and implant survival / success rate, this study design takes a more in depth approach and measures the exact marginal bone loss on each implant. In addition, other factors will be taken into consideration (implant type, smoking status, diabetes status) to eliminate any confounding factors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-19.
Trial Details
NCT Number NCT07550491
Lead Sponsor Saint-Joseph University
Conditions Residual Bone Height, Marginal Bone Loss, Implant Type, Smoking, Diabetes
Enrollment 142 participants
Start Date 2026-01-01
Primary Completion 2026-04-17 (estimated)
Study Completion 2026-04-17 (estimated)
Updated on ClinicalTrials.gov 2026-04-30